MarketPeel
Insider Trading Intelligence
Pricing
…
TC

Timothy Coughlin

TVTX
DIRECTOR · TRAVERE THERAPEUTICS, INC. · CIK 0001376043
FILING MIX · LIFETIME80%/20%
BUYS
39
SELLS
10
TOTAL VALUE
$2.00M
COMPANIES
6
ACTIVE SINCE
May 2020
HOLDINGS NOW
234,400
AVG SELL PX
$29.68
TRADE KIND
SHOWING 49 / 49
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Timothy Coughlin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-12.13%-3.34%-8.79%-8.79%—
14d2+100.00%-6.46%-5.99%-0.47%-0.47%—
30d2+0.00%+3.19%-3.50%+6.69%+6.69%—
60d2+0.00%+18.34%+0.28%+18.07%+18.07%—
90d2+50.00%+2.64%-0.63%+3.27%+3.27%—
180d2+50.00%+1.04%+2.24%-1.19%-1.19%—
1y2(1 pending)+100.00%-77.80%+6.00%-83.80%-83.80%—
2y2(1 pending)+100.00%-84.48%+32.64%-117.12%-117.12%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TVTX · 0 shares · as of Jun 12, 2026
018,37536,75055,12573,50020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 39 buys / 10 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
10,000——0Jun 12, 2026Jun 16, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,000$50.07$500.7K56,250Jun 12, 2026Jun 16, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
10,000$26.52$265.2K66,250Jun 12, 2026Jun 16, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000Jun 9, 2026Jun 10, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
16,000——16,000Jun 9, 2026Jun 10, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
8,000——16,000Jun 9, 2026Jun 10, 2026 ↗View →
VIR
VIR BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
8,000——8,000Jun 9, 2026Jun 10, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
SALE
12,600$3.08$38.8K72,400Jun 3, 2026Jun 3, 2026 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASEGRANT
Stock grant
45,000——85,000Jun 1, 2026Jun 3, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,000——56,250May 19, 2026May 21, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000May 19, 2026May 21, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,250$43.49$141.3K52,250May 15, 2026May 19, 2026 ↗View →
ATYR
ATYR PHARMA INC
PURCHASEGRANT
Stock grant
50,000——50,000May 11, 2026May 13, 2026 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
10,000$17.44$174.4K73,500Oct 31, 2025Nov 3, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASE
8,000$16.33$130.6K63,500Oct 31, 2025Nov 3, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
18,000$35.03$630.6K55,500Oct 31, 2025Nov 3, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
8,000——0Oct 31, 2025Nov 3, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
SALE
10,000——0Oct 31, 2025Nov 3, 2025 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASEGRANT
Stock grant
80,000——80,000Jun 3, 2025Jun 5, 2025 ↗View →
ADCT
ADC THERAPEUTICS SA
PURCHASEGRANT
Stock grant
40,000——40,000Jun 3, 2025Jun 5, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,500——55,500May 15, 2025May 16, 2025 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,500——19,500May 15, 2025May 16, 2025 ↗View →
ATYR
ATYR PHARMA INC
PURCHASEGRANT
Stock grant
50,000——50,000May 1, 2025May 2, 2025 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,000——40,000Jun 7, 2024Jun 11, 2024 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASE
50,000$1.75$87.5K56,000May 30, 2024Jun 3, 2024 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
24,000——24,000May 22, 2024May 23, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,500——49,000May 8, 2024May 10, 2024 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,500——19,500May 8, 2024May 10, 2024 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,000——40,000Jun 6, 2023Jun 7, 2023 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,500——42,500May 17, 2023May 19, 2023 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,500——13,500May 17, 2023May 19, 2023 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
12,000——12,000May 17, 2023May 19, 2023 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Gift
6,000——6,000May 17, 2023May 19, 2023 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
SALEGRANT
Gift
6,000——0May 17, 2023May 19, 2023 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASE
6,000——6,000Apr 26, 2023Apr 28, 2023 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
SALE
6,000——0Apr 26, 2023Apr 28, 2023 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
11,893——11,893Jun 9, 2022Jun 13, 2022 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,650——9,892Jun 9, 2022Jun 13, 2022 ↗View →
FATE
FATE THERAPEUTICS INC
SALE
1,439$22.81$32.8K57,632Jun 3, 2022Jun 6, 2022 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,000——9,000May 11, 2022May 12, 2022 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,000——38,000May 11, 2022May 12, 2022 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
6,000——6,000Apr 26, 2022Apr 28, 2022 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
2,681——59,071Jun 2, 2021Jun 4, 2021 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
4,334——4,334Jun 2, 2021Jun 4, 2021 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,000——9,000May 14, 2021May 18, 2021 ↗View →
TVTX
TRAVERE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,000——35,000May 14, 2021May 18, 2021 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
1,428——1,428Apr 28, 2021Apr 29, 2021 ↗View →
LIFE
ETHOS TECHNOLOGIES INC.
PURCHASEGRANT
Stock grant
1,428——1,428May 6, 2020May 8, 2020 ↗View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
16,000——16,000May 1, 2020May 5, 2020 ↗View →
Other insiders · TVTX
Loading peer insiders…
About this filer
CIK 0001376043
ROLE
Director
PRIMARY
TVTX
COMPANIES
6
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001376043DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback